Book a free demo
H-1B Data › Employers › CRISPR Therapeutics, Inc.
Check another employer
H-1B Sponsor Profile

CRISPR Therapeutics, Inc. — H-1B Visa Sponsorship Data

108 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.

Boston, MAActive FY2021–FY2026Transfer-FriendlyFull-Time RolesNot H-1B Dependent
● Data current through FY2026 · sourced from U.S. DOL OFLC, updated quarterly
Sponsors H-1B?
Yes
108 certified LCAs
FY2026 filings
12
most recent disclosure year
Median H-1B salary
$115,000
typical $95,215–$133,038
H-1B dependent?
No
per the employer's LCA attestation
Transfer share
27%
change-of-employer filings

3 items a DOL auditor would ask CRISPR Therapeutics, Inc. about

Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from CRISPR Therapeutics, Inc.'s own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.

1 need attention2 to watch3 clear
Needs attention
10 certified LCAs (10 positions) end within 180 days

Next end date: 2026-10-19. Employing an H-1B worker past the LCA end date without a new certified LCA is a strict-liability violation — the replacement LCA must be certified before the I-129 extension is filed.

Auditor asksWhich workers are on each expiring LCA, and is a superseding LCA already certified?
In your PAFSuperseding LCA, updated PAF entry and new posting notice for every position that continues.
Watch
4 worksites across 2 states

Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.

Auditor asksWhere is the posting record for each worksite, and were short-term placements tracked against the 30/60-day limits?
In your PAFPosting notices (or electronic-notice records) per worksite; new-worksite LCAs; placement log.
Watch
22% of LCAs denied or withdrawn (FY2024–FY2026)

Withdrawn or denied LCAs are normal in isolation; a high share suggests workers were moved between filings and the paper trail needs checking.

Auditor asksWere the workers on withdrawn LCAs re-covered by a valid certified LCA before continuing work?
In your PAFWithdrawal acknowledgements; superseding LCAs; PAF entries showing the transition.
Clear
10% of certified LCAs are at Wage Level I

Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.

Auditor asksHow was Level I justified for each role — required education, experience and the actual duties performed?
In your PAFPrevailing-wage determination and wage-level worksheet for every Level I LCA.
Clear
11% of LCAs offer a wage within 2% of the prevailing wage

Median offered wage is 13% above the DOL prevailing wage across 44 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.

Auditor asksShow the actual wage paid (payroll) matches or exceeds the LCA wage for every worker, including benched time.
In your PAFActual-wage memorandum and pay records per LCA; wage-level rationale where the offered wage equals the PW.
Clear
Not H-1B dependent (per LCA attestation)

No additional recruitment or non-displacement attestations apply.

Auditor asksDoes the current H-1B headcount still fall under the dependency threshold?
In your PAFHeadcount snapshot supporting the non-dependent attestation at each filing.
Are you CRISPR Therapeutics, Inc.? Get the private PAF / LCA gap check.
We compare these public filings against what must be in your Public Access Files and send you the gap list — free, within one business day. No platform migration, no commitment.
Get my private gap check →

Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.

For job seekers

Considering a job at CRISPR Therapeutics, Inc.?

Does CRISPR Therapeutics, Inc. sponsor H-1B visas?

Yes — CRISPR Therapeutics, Inc. is an active H-1B sponsor, with 108 certified LCAs on file (FY2021–FY2026), including 12 in FY2026. The median certified salary is $115,000 (P25 $95,215, P75 $133,038). With a 27% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.

What to Know Before Applying to CRISPR Therapeutics, Inc.

Salary range
Median $115,000, typical band $95,215–$133,038.
Transfers
27% of filings are transfers — this employer has an established H-1B transfer track record.
Typical locations
Boston, MA, Cambridge, MA, San Francisco, CA, South San Francisco, CA.
Position type
100% of filings are full-time roles.
Common roles
Research Associate Ii, Senior Research Associate, Senior Research Associate, Analytical .
Benchmark this employer in the H-1B database →
Looking for your next role?
See open positions on ElevateRecruit, the ElevateStaffing job board.
Browse open jobs →

Frequently asked questions

Yes. CRISPR Therapeutics, Inc. has 108 certified Labor Condition Applications (LCAs) on file with the U.S. Department of Labor (FY2021–FY2026).

The median sponsored salary is $115,000, with a typical P25–P75 band of $95,215–$133,038 across certified LCAs.

Yes — 27% of its LCA filings are change-of-employer (transfer) cases, indicating an active transfer pipeline.

No — the employer attests it is not H-1B dependent on its LCA filings.

CRISPR Therapeutics, Inc. filed 12 certified LCAs in FY2026, the most recent fiscal year of U.S. DOL disclosure data.

Top worksites include Boston, MA, Cambridge, MA, San Francisco, CA, South San Francisco, CA.
Sponsorship data

CRISPR Therapeutics, Inc. H-1B data at a glance

Executive Summary

CRISPR Therapeutics, Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).

  • Median certified salary is $115,000, typically $95,215–$133,038 (P25–P75).
  • 100% of certified filings are at or above the DOL prevailing wage.
  • Change-of-employer (transfer) share is 27% — workers actively transfer to this employer.
  • Worksite footprint spans 2 states and 4 cities.
  • Most-sponsored roles: Research Associate Ii, Senior Research Associate, Senior Research Associate, Analytical De.
  • Filed 12 certified LCAs in FY2026, the most recent disclosure year.

Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.

Salary Distribution

$75,000
$320,000
P25$95,215
Median$115,000
P75$133,038

The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.

100% of certified filings at or above the DOL prevailing wage.

Wage Level Distribution

Level I
10%
Level II
55%
Level III
15%
Level IV
20%

Levels I–IV are DOL prevailing-wage experience tiers; 35% of filings are senior-level (III–IV).

Filing history

LCA filings by fiscal year

Certified LCAs per year

FY2021
23
FY2022
20
FY2023
19
FY2024
21
FY2025
13
FY2026
12
Fiscal yearCertifiedDeniedWithdrawnTotal
FY2021230023
FY2022200020
FY2023190019
FY2024212629
FY2025130518
FY2026120012

Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.

See a single year in detail:
FY2021 ›FY2022 ›FY2023 ›FY2024 ›FY2025 ›FY2026 ›

All LCA filings

104 filings
Job titleSalaryLevelLocationFiledStatus
Scientist I, Translational Biology
I-200-26174-043549
$125,000/yrIIIBoston, MAJun 23, 2026Certified
Scientist I, Tech Ops
I-200-26174-043571
$126,946/yrIIIBoston, MAJun 23, 2026Certified
Manager, Clinical Data Management
I-200-26163-009484
$138,000/yrIIIBoston, MAJun 12, 2026Certified
Senior Research Associate, Analytical Development
I-200-26103-787700
$105,844/yrIIBoston, MAApr 13, 2026Certified
Research Associate II
I-200-26089-740871
$92,000/yrIVBoston, MAMar 30, 2026Certified
Associate Director, Regulatory Affairs
I-200-26083-725330
$195,000/yrIIIBoston, MAMar 24, 2026Certified
Associate Clinical Trial Manager
I-200-26014-560041
$124,919/yrIIBoston, MAJan 14, 2026Certified
Senior Medical Director, Pharmacovigilance
I-200-25350-485925
$320,000/yrIVBoston, MADec 16, 2025Certified
Senior Research Associate, Translational Biology
I-200-25317-405485
$102,000/yrIIBoston, MANov 13, 2025Certified
Principal Research Associate
I-200-25306-356554
$120,000/yrIIBoston, MANov 01, 2025Certified
Manager, Regulatory Affairs
I-200-25306-356583
$1,524,000/yrIBoston, MANov 01, 2025Certified
Principal Research Associate
I-200-25273-348354
$123,838/yrIIBoston, MASep 30, 2025Certified
Senior Manager, IT Business Applications (G&A)
I-200-25196-175923
$154,397/yrIIIBoston, MAJul 15, 2025Certified
Global Regulatory Lead, Director, Regulatory Affairs
I-200-25177-130428
$235,000/yrIIIBoston, MAJun 26, 2025Certified
Senior Research Associate, Analytical Development
I-200-25154-047351
$107,174/yrIIBoston, MAJun 03, 2025Certified
Senior Research Associate
I-200-25142-008842
$117,915/yr$56/hr as filedIIBoston, MAMay 22, 2025Certified, withdrawn
Principal Research Associate, CRISPR X
I-200-25134-975403
$127,077/yrIISouth San Francisco, CAMay 14, 2025Certified
Senior Research Associate
I-200-25126-942502
$107,675/yrIIBoston, MAMay 06, 2025Certified, withdrawn
Senior Research Associate
I-200-25126-942509
$107,675/yrIIBoston, MAMay 06, 2025Certified
Senior Scientist, General Tech Ops
I-200-25119-918326
$174,670/yrIVBoston, MAApr 29, 2025Certified
Senior Research Associate, Research
I-200-25107-877321
$109,158/yrIIBoston, MAApr 17, 2025Certified
Senior Research Associate, Analytical Development
I-200-25107-877297
$222,921,920/yr$107,174/hr as filedIIBoston, MAApr 17, 2025Certified
Research Associate II
I-200-25091-819834
$95,862/yrIBoston, MAApr 01, 2025Certified
Senior Manager, IT Business Applications
I-200-25091-819817
$155,931/yrIIIBoston, MAApr 01, 2025Certified
Scientist II
I-200-25079-791249
$144,472/yrIVBoston, MAMar 20, 2025Certified

One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.

Every certified LCA needs its own Public Access File. Get the private gap check →
Sponsorship insights

How CRISPR Therapeutics, Inc. sponsors H-1B talent

Petition Mix

New employment  38%Transfer (change of employer)  27%Continued employment  6%Amendments & other  28%
High transfer share (27%) — H-1B workers actively change employers to join CRISPR Therapeutics, Inc..

Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.

Filing Activity by Month

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Most active filing months: Mar and Jun — useful for timing transfer conversations.

Compliance Posture

H-1B Dependent
No
Willful Violator
No
Full-Time Positions
100%
At/Above Prevailing Wage
100%

Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.

Roles & geography

Top sponsored roles & worksites

Top job titles

Research Associate Ii
18 · $83,191
Senior Research Associate
18 · $100,715
Senior Research Associate, Analyti
9 · $99,300
Principal Research Associate
7 · $118,540
Manager, Qa Operations
5 · $123,400

Top worksite locations

2 states · 4 cities

Boston, MA
74
Cambridge, MA
43
San Francisco, CA
3
South San Francisco, CA
1
ElevateStaffing.ai Platform

Built for H-1B compliance teams

The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:

LCA & Public Access Files
Track every Labor Condition Application and auto-assemble the Public Access File within the DOL's 1-business-day window.
I-9 & E-Verify
Centralize I-9s and E-Verify status with automatic alerts before any work authorization lapses.
Visa & I-983 deadlines
Never miss an H-1B extension, EAD renewal, or STEM OPT I-983 evaluation — every deadline is tracked and alerted.
Audit & site-visit ready
FDNS site-visit and USCIS audit ready: every LCA posting, wage memo and document in one timestamped vault.
Explore more

Similar H-1B sponsors by filing volume

Sponsor H-1B talent? Know your gaps before an auditor does.

Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.

Get my private gap check →
CRISPR Therapeutics, Inc. · audit readiness
1 need attention2 to watch3 clear
Get my private gap check →